Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-06 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-03-25 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
BIOL | Biolase | 0.75 | 0.00 | -0.33% | 109.5M |
You can purchase shares of Biolase (NASDAQ: BIOL) through any online brokerage.
Other companies in Biolase’s space includes: LENSAR (NASDAQ:LNSR), Pro-Dex (NASDAQ:PDEX) and Venus Concept (NASDAQ:VERO).
The latest price target for Biolase (NASDAQ: BIOL) was reported by Maxim Group on 2020-10-14. The analyst firm set a price target for 1.00 expecting BIOL to rise to within 12 months (a possible 33.33% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Biolase (NASDAQ: BIOL) is $0.75 last updated Fri Mar 05 2021 21:00:01 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Biolase. The last dividend paid out to investors was $0.00 on 2013-06-12.
There is no upcoming split for Biolase.